Table 7 Sensitivity, Specificity, PPV, and NPV at optimal cutoffs with AUC regarding tumor size (0–1 cm)
Gene | Sensitivity | Specificity | PPV | NPV | AUC | 95% CI |
|---|---|---|---|---|---|---|
CDO1 | 82% | 46% | 66% | 67% | 0.64 | 0.49–0.80 |
TAC1 | 61% | 78% | 78% | 61% | 0.68 | 0.56–0.81 |
SOX17 | 61% | 77% | 77% | 61% | 0.68 | 0.56–0.80 |
HOXA7 | 82% | 59% | 72% | 72% | 0.73 | 0.60–0.87 |
CDO1, TAC1, SOX17 | 71% | 82% | 83% | 69% | 0.81 | 0.69–0.93 |
CDO1, SOX17, HOXA7 | 64% | 82% | 82% | 64% | 0.75 | 0.62–0.89 |